Geode Capital Management, LLC Fennec Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 299,298 shares of FENC stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
299,298
Previous 301,578 0.76%
Holding current value
$1.79 Million
Previous $1.84 Million 18.78%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$4.85 - $6.73 $11,058 - $15,344
-2,280 Reduced 0.76%
299,298 $1.5 Million
Q2 2024

Aug 09, 2024
BUY
$6.02 - $10.99 $492,580 - $899,245
81,824 Added 37.23%
301,578 $1.84 Million
Q1 2024

May 13, 2024
BUY
$8.82 - $11.12 $10,266 - $12,943
1,164 Added 0.53%
219,754 $2.44 Million
Q4 2023

Feb 13, 2024
BUY
$6.48 - $11.61 $80,293 - $143,859
12,391 Added 6.01%
218,590 $2.45 Million
Q3 2023

Nov 13, 2023
BUY
$7.15 - $8.94 $66,652 - $83,338
9,322 Added 4.73%
206,199 $1.55 Million
Q2 2023

Aug 11, 2023
BUY
$7.27 - $9.82 $1.29 Million - $1.74 Million
177,370 Added 909.26%
196,877 $1.74 Million
Q1 2022

May 13, 2022
SELL
$4.29 - $6.08 $480 - $680
-112 Reduced 0.57%
19,507 $109,000
Q4 2021

Feb 11, 2022
SELL
$3.89 - $10.01 $1,128 - $2,902
-290 Reduced 1.46%
19,619 $86,000
Q3 2021

Nov 12, 2021
BUY
$6.51 - $9.62 $12,909 - $19,076
1,983 Added 11.06%
19,909 $187,000
Q2 2021

Aug 13, 2021
SELL
$5.96 - $7.85 $902,522 - $1.19 Million
-151,430 Reduced 89.42%
17,926 $130,000
Q1 2021

May 12, 2021
BUY
$6.21 - $8.68 $9,395 - $13,132
1,513 Added 0.9%
169,356 $1.05 Million
Q4 2020

Feb 12, 2021
BUY
$5.99 - $8.55 $72,215 - $103,078
12,056 Added 7.74%
167,843 $1.25 Million
Q3 2020

Nov 13, 2020
BUY
$5.19 - $10.17 $28,996 - $56,819
5,587 Added 3.72%
155,787 $944,000
Q2 2020

Aug 13, 2020
BUY
$5.43 - $9.39 $815,586 - $1.41 Million
150,200 New
150,200 $1.25 Million
Q2 2019

Aug 14, 2019
SELL
$3.3 - $5.09 $151,994 - $234,440
-46,059 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$4.64 - $7.58 $30,484 - $49,800
6,570 Added 16.64%
46,059 $223,000
Q4 2018

Feb 13, 2019
BUY
$5.37 - $8.39 $29,218 - $45,649
5,441 Added 15.98%
39,489 $251,000
Q3 2018

Nov 13, 2018
BUY
$7.84 - $10.83 $37,624 - $51,973
4,799 Added 16.41%
34,048 $279,000
Q2 2018

Aug 14, 2018
BUY
$10.05 - $14.33 $293,952 - $419,138
29,249 New
29,249 $305,000

Others Institutions Holding FENC

# of Institutions
64
Shares Held
14.9M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $156M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email